Pdt Partners, LLC Eagle Pharmaceuticals, Inc. Transaction History

Pdt Partners, LLC

$1.02 Billion
Q3 2024

A detailed history of Pdt Partners, LLC transactions in Eagle Pharmaceuticals, Inc. stock. As of the latest transaction made, Pdt Partners, LLC holds 30,011 shares of EGRX stock, worth $21,007. This represents 0.01% of its overall portfolio holdings.

Number of Shares

30,011

Previous 30,011 -0.0%

Holding current value

$21,007

Previous $168,000 33.93%

% of portfolio

0.01%

Previous 0.02%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 15, 2024	BUY	$3.34 - $5.6 $9,863 - $16,536	2,953 Added 10.91%	30,011 $168,000
Q1 2024 May 15, 2024	BUY	$4.26 - $6.51 $115,267 - $176,147	27,058 New	27,058 $141,000
Q3 2023 Nov 14, 2023	BUY	$15.21 - $22.88 $300,321 - $451,765	19,745 New	19,745 $311,000
Q1 2020 May 15, 2020	SELL	$34.37 - $60.07 $1.26 Million - $2.2 Million	-36,701 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$54.32 - $64.31 $946,417 - $1.12 Million	-17,423 Reduced 32.19%	36,701 $2.21 Million
Q3 2019 Nov 14, 2019	SELL	$53.25 - $59.98 $51,972 - $58,540	-976 Reduced 1.77%	54,124 $3.06 Million
Q2 2019 Aug 14, 2019	SELL	$46.61 - $58.45 $652 - $818	-14 Reduced 0.03%	55,100 $3.07 Million
Q1 2019 May 15, 2019	BUY	$38.66 - $51.82 $417,643 - $559,811	10,803 Added 24.38%	55,114 $2.78 Million
Q4 2018 Feb 14, 2019	SELL	$36.72 - $67.73 $1.04 Million - $1.92 Million	-28,289 Reduced 38.97%	44,311 $1.79 Million
Q3 2018 Nov 14, 2018	SELL	$66.65 - $83.86 $759,210 - $955,249	-11,391 Reduced 13.56%	72,600 $5.03 Million
Q2 2018 Aug 14, 2018	BUY	$51.25 - $76.62 $12,812 - $19,155	250 Added 0.3%	83,991 $6.36 Million
Q1 2018 May 15, 2018	SELL	$52.16 - $66.86 $1.15 Million - $1.48 Million	-22,096 Reduced 20.88%	83,741 $4.41 Million
Q4 2017 Feb 14, 2018	BUY	$49.6 - $60.87 $5.25 Million - $6.44 Million	105,837	105,837 $5.65 Million

Others Institutions Holding EGRX

# of Institutions

Shares Held

8.58M

Call Options Held

Put Options Held

100

View Full List

About EAGLE PHARMACEUTICALS, INC.

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $9.11M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

More about EGRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pdt Partners, LLC with notifications on news.

Account